Quarterly report [Sections 13 or 15(d)]

Equity (Details)

v3.25.3
Equity (Details) - USD ($)
$ / shares in Units, $ in Thousands
 1 Months Ended 9 Months Ended
Mar. 31, 2025
Aug. 11, 2023
Aug. 31, 2020
Sep. 30, 2025
Sep. 30, 2024
Equity [Line Items]          
Gross proceeds       $ 29,256
Issuance of stock options (in Shares)       36,000  
Vesting period       4 years  
Aggregated fair value       $ 41  
Expected life       6 years  
Expected volatility minimum       90.10%  
Expected volatility maximum       90.70%  
Expected dividends        
Stock option grant (in Shares)         104
Cancellation of stock options (in Shares)       5,012,000  
Capital on Demand Sales Agreement [Member]          
Equity [Line Items]          
Aggregate amount     $ 200,000    
Restricted Stock Units (RSUs) [Member]          
Equity [Line Items]          
Aggregated fair value       $ 1,800  
Compensation expense       $ 400 $ 400
Stock Options [Member]          
Equity [Line Items]          
Option term       10 years  
Cancellation of stock options       $ 8,800  
Compensation expense         $ 3,600
Unrecognized compensation expense       $ 100  
Weighted average term       2 years 4 months 24 days  
Minimum [Member]          
Equity [Line Items]          
Discount rate       4.00%  
Maximum [Member]          
Equity [Line Items]          
Discount rate       4.50%  
Common Stock [Member]          
Equity [Line Items]          
Aggregate amount   $ 200,000      
Base prospectus   $ 500,000      
Sale of shares (in Shares)         3,500,000
Gross proceeds         $ 29,900
Net proceeds from issuance of common stock.         $ 29,300
Issuance of stock options (in Shares)       36,000  
Exercise price minimum (in Dollars per share)       $ 1.06  
Exercise price maximum (in Dollars per share)       $ 1.55  
Cancellation of stock options (in Shares) 4,900,000